The pragmatist's guide to comparative effectiveness research

Journal of Economic Perspectives

Volumn 25, Issue 2, 2011, Pages 27-46

  Chandra, Amitabh ^a,d,e   Jena, Anupam B ^b,d,e   Skinner, Jonathan S ^c,d,e  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^d DARTMOUTH COLLEGE   (United States)

^e NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE EFFECTIVENESS; COST BENEFIT ANALYSIS; ECONOMICS; FORECASTING; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; QUALITY ADJUSTED LIFE YEAR; SURVIVAL; UNITED STATES;

COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; FORECASTING; GOVERNMENT PROGRAMS; HEALTH CARE COSTS; HEALTH CARE REFORM; HUMANS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; QUALITY-ADJUSTED LIFE YEARS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 79957497518     PISSN: None     EISSN: 08953309     Source Type: Journal    
DOI: 10.1257/jep.25.2.27     Document Type: Conference Paper

References (62)

1. Adams, Christopher P., and Van V. Brantner. 2006. "Estimating the Cost of New Drug Development: Is It Really $802 Million?" Health Affairs, 25(2): 420-28. (Pubitemid 43529550)
2. Almond, Douglas, Joseph Doyle, Amanda Kowalski, and Heidi Williams. 2010. "Estimating Marginal Returns to Medical Care: Evidence from At-Risk Newborns." Quarterly Journal of Economics, 125(2): 591-634.
3. Baicker, Katherine, and Amitabh Chandra. 2010. "Uncomfortable Arithmetic-Whom to Cover versus What to Cover." New England Journal of Medicine, 362 (2): 95-97.
4. Baicker, Katherine, and Jonathan S. Skinner. 2011. "Health Care Spending Growth and the Future of U.S. Tax Rates." NBER Working Paper 16772.
5. Basu, Anirban, and Tomas Philipson. 2010. "The Impact of Comparative Effectiveness Research on Health and Health Care Spending." NBER Working Paper 15633.
6. Boden, William E., Robert A. O'Rourke, Koon K. Teo et al., the COURAGE Trial Research Group. 2007. "Optimal Medical Therapy with or without PCI for Stable Coronary Disease." New England Journal of Medicine, 356(15): 1503-16. (Pubitemid 46588415)
7. Brenner, David J., and Eric J. Hall. 2007. "Computerized Tomography-An Increasing Source of Radiation Exposure." New England Journal of Medicine, 357(22): 2277-84. (Pubitemid 350190758)
8. Buntin, Melinda Beeuwkes, and David M. Cutler. 2009. "The Two Trillion Dollar Solution: Saving Money by Modernizing the Health Care System." Center for American Progress. Available at: http://www. americanprogress.org/issues/2009/06/2trillion-solution.html.
9. Chandra, Amitabh, and Jonathan Skinner. Forthcoming. "Technology Growth and Expenditure Growth in Health Care." Journal of Economic Literature.
10. Chandra, Amitabh, and Douglas O. Staiger. 2007. "Productivity Spillovers in Healthcare: Evidence from the Treatment of Heart Attacks." Journal of Political Economy, 115(February): 103-140. (Pubitemid 46464377)
11. Chernew, Michael E., Allison B. Rosen, and A. Mark Fendrick. 2007. "Value Based Insurance Design." Health Affairs, 26(2): 195-203.
12. Concato, John, Nirav Shah, and Ralph I. Horwitz. 2000. "Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs." New England Journal of Medicine, 342(25): 1887-92. (Pubitemid 30419054)
13. Congressional Budget Office. 2007. "Research on the Comparative Effectiveness of Medical Treatments: Issues and Options for an Expanded Federal Role." http://www.cbo.gov/ftpdocs/88xx/doc8891/Frontmatter.1.2.shtml.
14. Cutler, David M. 2004. "Your Money or Your Life: Strong Medicine for America's Health Care System." New York: Oxford University Press.
15. Cutler, David M., and Mark McClellan. 2001. "Is Technological Change in Medicine Worth It?" Health Affairs, 20(5): 11-29. (Pubitemid 33710338)
16. DiMasi, Joseph A., Ronald W. Hansen, and Henry G. Grabowski. 2003. "The Price of Innovation: New Estimates of Drug Development Costs." Journal of Health Economics, 22(2): 151-85. (Pubitemid 36279392)
17. Dorsey, E. Ray, and David O. Meltzer. 2010. "The Economics of Comparative Effectiveness Research." Neurology, 75(6): 492-493.
18. Ferguson, John H., Michael Dubinsky, and Peter J. Kirsch. 1993. Journal of the American Medical Association, 269(16): 2116-21.
19. Fisher, Elliott, Dan Gottlieb, and David Wennberg. 2004. "Implications of Regional Differences in Spending." Annals of Internal Medicine, 140(2): 148-49.
20. Garber, Alan M., and Charles E. Phelps. 1997. "Economic Foundations of Cost-Effectiveness Analysis." Journal of Health Economics, 16(1): 1-31. (Pubitemid 27224092)
21. Garber, Alan M., and Jonathan Skinner. 2008. "Is American Health Care Uniquely Inefficient?" Journal of Economic Perspectives, 22(4): 27-50.
22. Garber, Alan M., and Harold C. Sox. 2010. "The Role of Costs in Comparative Effectiveness Research." Health Affairs, 29(10): 1806-07.
23. Garber, Alan M., and Sean R. Tunis. 2009. "Does Comparative Effectiveness Research Threaten Personalized Medicine?" New England Journal of Medicine, 360(19): 1925-27.
24. Gawande, Atul. 2007. Better: A Surgeon's Notes on Performance. Metropolitan Books.
25. Groopman, Jerome. 2010. "Health Care: Who Knows 'Best'?" New York Review of Books, February 11.
26. Hadorn, David. 1991. "Setting Health Care Priorities in Oregon: Cost-Effectiveness Meets the Rule of Rescue." JAMA, 265(17): 2218-25.
27. Hartwell, D., J. Colquitt, E. Loveman, A. J. Clegg, H. Brodin, N. Waugh, P. Royle, P. Davidson, L. Vale, and L. MacKenzie. 2005. "Clinical Effectiveness and Cost-Effectiveness of Immediate Angioplasty for Acute Myocardial Infarction: Systematic Review and Economic Evaluation." Health Technology Assessment, 9(17): 1-4.
28. Hawker, Gillian, Jun Guan, Andy Judge, and Paul Dieppe. 2008. "Knee Arthroscopy in England and Ontario: Patterns of Use, Changes over Time, and Relationship to Total Knee Replacement." Journal of Bone and Joint Surgery, 90A(11): 2337-45.
29. Jena, Anupam, and Tomas Philipson. 2010. "Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption." NBER Working Paper 15032.
30. Kim, J. Yong, Aaron Shakow, Kedar Mate, Chris Vanderwarker, Rajesh Gupta, and Paul Farmer. 2005. "Limited Good and Limited Vision: Multidrug-Resistant Tuberculosis and Global Health Policy." Social Science and Medicine, 61(4): 847-59. (Pubitemid 40798579)
31. Lazar, Kay. 2009. "The Long Run: Cutting Question." The Boston Globe, August 24, G.6, Living Arts.
32. Lee, Chris P., Clenn M. Chertow, and Stefanos A. Zenios. 2009. "An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard." Value in Health, 12(1): 80-87.
33. Marchione, Marulynn. 2010, "$93,000 Cancer Drug: How Much is a Life Worth?" Associated Press, September 26.
34. Martin, Daniel F., Maureen G. Maguire, and Stuart L. Fine. 2010. "Identifying and Eliminating the Roadblocks to Comparative-Effectiveness Research." New England Journal of Medicine, 363(2): 105-107.
35. McClellan, Mark, Barbara McNeil, and Joseph Newhouse. 1994. "Does More Intensive Treatment of Acute Myocardial Infarction Reduce Mortality?" JAMA, 272(11): 859-66.
36. McGrath Paul D., David E. Wennberg, John D. Dickens Jr., Andrea E. Siewers F. Lee Lucas, David J. Malenka, Merle A. Kellett Jr., and Thomas J. Ryan Jr. 2000. "Relation between Operator and Hospital Volume and Outcomes following Percutaneous Coronary Interventions in the Era of the Coronary Stent." JAMA, 284(24): 3139-44. (Pubitemid 32039076)
37. Meltzer, David. 1997. "Accounting for Future Costs in Medical Cost-Effectiveness Analysis." Journal of Health Economics, 16(1):33-64. (Pubitemid 27224093)
38. Morgan, Matthew W., Raisa B. Deber, Hilary A. Llewellyn-Thomas, Peter Gladstone, R. J. Cusimano, Keith O'Rourke, George Tomlinson, and Alan S. Detsky. 2000. "Randomized, Controlled Trial of an Interactive Videodisc Decision Aid for Patients with Ischemic Heart Disease." Journal of General Internal Medicine, 15(10): 685-93.
39. Mosley, J. Bruce, et al. 2002. "A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee." New England Journal of Medicine, 347(2): 81-8.
40. Murphy, Kevin M., and Robert H. Topel. 2006. "The Value of Health and Longevity." Journal of Political Economy, 114(5): 871-904. (Pubitemid 44734045)
41. Murphy, Kevin M., and Robert H. Topel. 2006. "The Value of Health and Longevity." Journal of Political Economy, 114(5): 871-904. (Pubitemid 44734045)
42. Nathan, David M. 2010. "Time for Clinically Relevant Comparative Effectiveness Studies in Type 2 Diabetes." Annals of Internal Medicine, December. Available at: http://www.annals.org/content/early/2010/12/06/0003- 4819-154-2-201101180-00303?col3.
43. Newhouse, Joseph P. 2010. "Assessing Health Reform's Impact on Four Key Groups of Americans." Health Affairs, 29(9): 1714-24.
44. Nord, Erik, Jeff Richardson, Andrew Street, Helga Kuhse, and Peter Singer. 1995. "Who Cares about Cost? Does Economic Analysis Impose or Refl ect Social Values?" Health Policy, 34(2): 79-94.
45. Pearson, Steven D., and Peter B. Bach. 2010. "How Medicare Could Use Comparative Effectiveness Research in Deciding on New Coverage and Reimbursement." Health Affairs, 29(10): 1796-1804.
46. Perlroth, Daniella J., Dana P. Goldman, and Alan Garber. 2010. "The Potential Impact of Comparative Effectiveness Research on U.S. Health Care Expenditures. Demography, 47(Suppl.): S173-S190.
47. Polinski, Jennifer M., Philip S. Wang, and Michael A. Fisher. 2007. "Medicaid's Prior Authorization Program and Access to Atypical Antipsychotic Medications." Health Affairs, 26(3): 750-60.
48. Robberstad, Bjarne. 2005. "QALYs vs DALYs vs LYs Gained: What are the Differences, and What Difference Do They Make for Health Care Priority Setting?" Norsk Epidemiologi, 15(2): 183-91. (Pubitemid 43197903)
49. Rothberg, Michael B., Senthil K. Sivalingam, Javed Ashraf, Paul Visintainer, John Joelson, Reval Klippel, Neelima Vallurupalli, and Marc J. Schweiger. 2010. "Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease." Annals of Internal Medicine, 153(5): 307-13.
50. Sack, Kevin. 2011. "Feeling Budget Pinch, States Cut Insurance." The New York Times, March 2.
51. Shah, Nilay D., Victor M. Montori, Harlan M. Krumholz, Karen Tu, Caleb Alexander, and Cynthia Jackevicius. 2010. "Responding to an FDA Warning-Geographic Variation in the Use of Rosiglitazone." New England Journal of Medicine, 363(22): 2081-84.
52. Sirovich, Brenda, Patricia M. Gallagher, David E. Wennberg, and Elliott S. Fisher. 2008. "Discretionary Decision Making by Primary Care Physicians and the Cost of U.S. Health Care." Health Affairs, 27(3): 813-23. (Pubitemid 351770251)
53. Skinner, Jonathan S., Elliott S. Fisher, and John Wennberg. 2005. "The Efficiency of Medicare." In Analyses in the Economics of Aging, ed. David A. Wise, 129-60. Chicago: University of Chicago Press.
54. Skinner, Jonathan, Douglas Staiger, and Elliott Fisher. 2006. "Is Technological Change in Medicine Always Worth It? The Case of Acute Myocardial Infarction." Health Affairs, 25(2): w34-247.
55. Sunstein, Cass, and Richard Thaler. 2008. Nudge: Improving Decisions about Health, Wealth, and Happiness. Yale University Press.
56. Taubes, Gary. 2007. "Do We Really Know What Makes Us Healthy?" New York Times Magazine, September 16.
57. Temel, Jennifer S., et al. 2010. "Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer." New England Journal of Medicine, 393(8): 733-42.
58. U.S. Congress. 2010. Patient Protection and Affordable Care Act. H.R. 3590, 111th Congress of the United States, Second Session.
59. Weinstein, Milton C., and Jonathan A. Skinner. 2010. "Comparative Effectiveness and Health Care Spending-Implications for Reform." New England Journal of Medicine, 362(5): 460-65.
60. Weintraub, William S. et al. 2008. "Effect of PCI on Quality of Life in Patients with Stable Coronary Disease." New England Journal of Medicine, 359(7): 677-87.
61. Wennberg, David E., F. L. Lucas, John D. Birkmeyer, Carl E. Bredenberg, and Elliott S. Fisher. 1998. "Variations in Carotid Endarterectomy Mortality in the Medicare Population: Trial Hospitals, Volume, and Patient Characteristics." JAMA, 279(16): 1278-81. (Pubitemid 28180780)
62. Winkelmayer, Wolfgang C., Milton C. Weinstein, Murray A. Mittleman, Robert J. Glynn, and Joseph S. Pliskin. 2002. "Health Economic Evaluations: The Special Case of End-Stage Renal Disease Treatment." Medical Decision Making, 22(5): 417-30.